Tumor-to-tumor metastasis: Lung adenocarcinoma metastasizing to a follicular variant of papillary thyroid carcinoma

Pathology International

Volumn 61, Issue 7, 2011, Pages 435-441

  Hashimoto, Kazuki ^a   Yamamoto, Hidetaka ^a   Nakano, Takafumi ^a   Oyama, Minako ^a   Shiratsuchi, Hideki ^a   Nakashima, Torahiko ^a   Tamiya, Sadafumi ^a   Komune, Shizuo ^a   Oda, Yoshinao ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

EGFR; Follicular variant; Lung adenocarcinoma; Papillary thyroid carcinoma; Thyroid; Tumor to tumor metastasis

Indexed keywords

B RAF KINASE; CARCINOEMBRYONIC ANTIGEN; EPIDERMAL GROWTH FACTOR RECEPTOR;

ADULT; ARTICLE; CASE REPORT; EXON; FEMALE; GENE MUTATION; GENOTYPE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG BIOPSY; METASTASIS; ONCOGENE H RAS; ONCOGENE N RAS; PRIORITY JOURNAL; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; FEMALE; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; MUTATION; QUINAZOLINES; RECEPTOR, EPIDERMAL GROWTH FACTOR; THYROID NEOPLASMS; TREATMENT OUTCOME;

EID: 79959651254     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2011.02679.x     Document Type: Article

References (22)

1. Moriya T, Manabe T, Yamashita K etal. Lung cancer metastasis to adrenocortical adenomas. A chance occurrence or a predilected phenomenon? Arch Pathol Lab Med 1988; 112: 286-9.
2. Baloch ZW, LiVolsi VA. Tumor-to-tumor metastasis to follicular variant of papillary carcinoma of thyroid. Arch Pathol Lab Med 1999; 123: 703-6.
3. Yu J, Nikiforova MN, Hodak SP etal. Tumor-to-tumor metastases to follicular variant of papillary thyroid carcinoma: Histologic, immunohistochemical, and molecular studies of two unusual cases. Endocr Pathol 2009; 20: 235-42.
4. Bohn OL, De las Casas LE, Leon ME. Tumor-to-tumor metastasis: Renal cell carcinoma metastatic to papillary carcinoma of thyroid-report of a case and review of the literature. Head Neck Pathol 2009; 3: 327-30.
5. Mori K, Kitazawa R, Kondo T etal. Lung adenocarcinoma with micropapillary component presenting with metastatic scrotum tumor and cancer-to-cancer metastasis: A case report. Cases J 2008; 1: 162.
6. Terzi A, Altundag K, Saglam A etal. Isolated metastasis of malignant melanoma into follicular carcinoma of the thyroid gland. J Endocrinol Invest 2004; 27: 967-8.
7. Witt RL. Colonic adenocarcinoma metastatic to thyroid Hürthle cell carcinoma presenting with airway obstruction. Del Med J 2003; 75: 285-8.
8. Ryska A, Cáp J. Tumor-to-tumor metastasis of renal cell carcinoma into oncocytic carcinoma of the thyroid. Report of a case and review of the literature. Pathol Res Pract 2003; 199: 101-6.
9. Rosai J, Carcangiu ML, Delellis RA. Secondary tumors. In: Rosai J, Sobin LH, eds. Atlas of Tumor Pathology. Tumors of the Thyroid Gland, Third Series. Washington, DC: Armed Forces Institute of Pathology, 1992; 289-96.
10. Peteiro A, Duarte AM, Honavar M. Breast carcinoma metastatic to follicular adenoma of the thyroid gland. Histopathology 2005; 46: 587-8.
11. Qian L, Pucci R, Castro CY etal. Renal cell carcinoma metastatic to Hürthle cell adenoma of thyroid. Ann Diagn Pathol 2004; 8: 305-8.
12. Fadare O, Parkash V, Fiedler PN etal. Tumor-to-tumor metastasis to a thyroid follicular adenoma as the initial presentation of a colonic adenocarcinoma. Pathol Int 2005; 55: 574-9.
13. Temam S, Kawaguchi H, El-Naggar AK etal. Epidermal growth factor receptor copy number alterations correlate with poor clinical outcome in patients with head and neck squamous cancer. J Clin Oncol 2007; 25: 2164-70.
14. Asano H, Toyooka S, Tokumo M etal. Detection of EGFR gene mutation in lung cancer by mutant-enriched polymerase chain reaction assay. Clin Cancer Res 2006; 12: 43-8.
15. Fujita K, Yamamoto H, Matsumoto T etal. Sessile serrated adenoma with early neoplastic progression: A clinicopathological and molecular study. Am J Surg Pathol 2011; 35: 295-304.
16. Akslen LA, Puntervoll H, Bachmann IM etal. Mutation analysis of the EGFR-NRAS-BRAF pathway in melanomas from black Africans and other subgroups of cutaneous melanoma. Melanoma Res 2008; 18: 29-35.
17. Bastian BC, LeBoit PE, Pinkel D. Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features. Am J Pathol 2000; 157: 967-72.
18. DeLellis RA. Secondary tumours of the thyroid. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C, eds. World Health Organization Classification of Tumors. Pathology and Genetics. Tumours of Endocrine Organs. Lyon: IARC Press, 2004; 122-3.
19. Yamamoto H, Toyooka S, Mitsudomi T. Impact of EGFR mutation analysis in non-small cell lung cancer. Lung Cancer 2009; 63: 315-21.
20. Mitsiades CS, Kotoula V, Poulaki V etal. Epidermal growth factor receptor as a therapeutic target in human thyroid carcinoma: Mutational and functional analysis. J Clin Endocrinol Metab 2006; 91: 3662-6.
21. Santarpia L, Myers JN, Sherman SI etal. Genetic alterations in the RAS/RAF/mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways in the follicular variant of papillary thyroid carcinoma. Cancer 2010; 116: 2974-83.
22. Trovisco V, Soares P, Sobrinho-Simões M. B-RAF mutations in the etiopathogenesis, diagnosis, and prognosis of thyroid carcinomas. Hum Pathol 2006; 37: 781-6.